Processing of Anti-Müllerian Hormone Regulates Receptor Activation by a Mechanism Distinct from TGF-β
Open Access
- 1 November 2010
- journal article
- other
- Published by The Endocrine Society in Molecular Endocrinology
- Vol. 24 (11) , 2193-2206
Abstract
TGF-β family ligands are translated as prepropeptide precursors and are processed into mature C-terminal dimers that signal by assembling a serine/threonine kinase receptor complex containing type I and II components. Many TGF-β ligands are secreted in a latent form that cannot bind their receptor, due to the pro-region remaining associated with the mature ligand in a noncovalent complex after proteolytic cleavage. Here we show that anti-Müllerian hormone (AMH), a TGF-β family ligand involved in reproductive development, must be cleaved to bind its type II receptor (AMHRII), but dissociation of the pro-region from the mature C-terminal dimer is not required for this initial interaction. We provide direct evidence for this interaction by showing that the noncovalent complex binds to a soluble form of AMHRII in an ELISA format and to AMHRII immobilized on Sepharose. Binding of the noncovalent complex to Sepharose-coupled AMHRII induces dissociation of the pro-region from the mature C-terminal dimer, whereas no dissociation occurs after binding to immobilized AMH antibodies. The pro-region cannot be detected after binding of the AMH noncovalent complex to AMHRII expressed on COS cells, indicating that pro-region dissociation may occur as a natural consequence of receptor engagement on cells. Moreover, the mature C-terminal dimer is more active than the noncovalent complex in stimulating Sma- and Mad-related protein activation, suggesting that pro-region dissociation contributes to the assembly of the active receptor complex. AMH thus exemplifies a new mechanism for receptor engagement in which interaction with the type II receptor promotes pro-region dissociation to generate mature ligand.Keywords
This publication has 52 references indexed in Scilit:
- Receptor oligomerization and beyond: a case study in bone morphogenetic proteinsBMC Biology, 2009
- A New Model for Growth Factor Activation: Type II Receptors Compete with the Prodomain for BMP-7Journal of Molecular Biology, 2008
- Functional Redundancy of TGF-beta Family Type I Receptors and Receptor-Smads in Mediating Anti-Müllerian Hormone-Induced Müllerian Duct Regression in the Mouse1Biology of Reproduction, 2008
- Crystal Structure of BMP-9 and Functional Interactions with Pro-region and ReceptorsJournal of Biological Chemistry, 2005
- Mechanisms of TGF-β Signaling from Cell Membrane to the NucleusCell, 2003
- Transduction pathway of anti-Müllerian hormone, a sex-specific member of the TGF-β familyTrends in Endocrinology & Metabolism, 2003
- Requirement of Bmpr1a for Müllerian duct regression during male sexual developmentNature Genetics, 2002
- Engagement of Bone Morphogenetic Protein Type IB Receptor and Smad1 Signaling by Anti-Müllerian Hormone and Its Type II ReceptorJournal of Biological Chemistry, 2000
- A mouse Sertoli cell line expressing anti-Müllerian hormone and its type II receptorMolecular and Cellular Endocrinology, 1997
- Imidazole‐SDS‐Zn reverse staining of proteins in gels containing or not SDS and microsequence of individual unmodified electroblotted proteinsFEBS Letters, 1992